Host subversion by formation of intracellular bacterial communities in the urinary tract

Microbes and Infection
Gregory G AndersonS J Hultgren

Abstract

Urinary tract infections pose a serious health threat with respect to antibiotic resistance and high recurrence rates. While the host robustly responds to bacterial infiltration into the bladder, uropathogenic Escherichia coli can survive the onslaught to persist for months after initially infecting. To accomplish this feat, uropathogenic E. coli forms intracellular bacterial communities, with many biofilm-like properties, within the bladder epithelium. These communities may allow bacteria to subvert host defenses and form a persistent reservoir in the bladder.

References

Oct 6, 1997·Infectious Disease Clinics of North America·C Svanborg, G Godaly
Oct 6, 1997·Infectious Disease Clinics of North America·T M Hooton, W E Stamm
Feb 26, 1999·The Journal of Urology·J Jones-CarsonD T Uehling
Mar 2, 1999·Journal of Structural Biology·D L Hung, S J Hultgren
Sep 9, 1999·The Journal of Infectious Diseases·M HaraokaC Svanborg
Aug 2, 2000·Proceedings of the National Academy of Sciences of the United States of America·M A MulveyS J Hultgren
Dec 12, 2001·American Journal of Physiology. Renal Physiology·Weidong WangSøren Nielsen
Dec 18, 2001·The Journal of Biological Chemistry·Indira U MysorekarJeffrey I Gordon
Feb 22, 2002·Cellular Microbiology·Juan J Martinez, Scott J Hultgren
Apr 5, 2002·Clinical Microbiology Reviews·W Michael Dunne
Apr 5, 2002·Clinical Microbiology Reviews·Rodney M Donlan, J William Costerton
May 16, 2002·Molecular Microbiology·Chia-Suei HungScott J Hultgren
May 25, 2002·Cellular Microbiology·Matthew A Mulvey
Jul 13, 2002·The American Journal of Medicine·Linda M Dairiki Shortliffe, Jack D McCue
Dec 24, 2002·Current Opinion in Immunology·Shizuo Akira
Mar 26, 2003·Proceedings of the National Academy of Sciences of the United States of America·Joel D SchillingScott J Hultgren
Jul 5, 2003·Science·Gregory G AndersonScott J Hultgren
Jan 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Sheryl S JusticeScott J Hultgren
Feb 10, 2004·Journal of Clinical Microbiology·Marc AndersonTodd R Steck

❮ Previous
Next ❯

Citations

Jan 27, 2006·Der Urologe. Ausg. A·U GrigoleitM Stöhrer
Feb 7, 2012·Asian Pacific Journal of Tropical Medicine·Poovendran PonnusamyMurugan Sevanan
Aug 1, 2007·Antimicrobial Agents and Chemotherapy·S V LynchA Matin
Aug 29, 2007·Infection and Immunity·Benjamin K BillipsAnthony J Schaeffer
Sep 18, 2012·Journal of Bacteriology·Maria HadjifrangiskouScott J Hultgren
Apr 19, 2013·Journal of Clinical Microbiology·Rajvinder KhasriyaJames Malone-Lee
Oct 25, 2011·BMC Pediatrics·Ruth B ThorntonPeter C Richmond
Mar 23, 2007·Clinical Pharmacokinetics·Florian M E WagenlehnerKurt G Naber
Aug 1, 2010·Toxins·Chiou-Feng LinMing-Yuan Hong
Sep 8, 2012·Future Microbiology·Thien-Fah Mah
Jul 31, 2007·Future Microbiology·Kelly J Wright, Scott J Hultgren
Mar 1, 2014·Urological Science·Matthew GloverPhilippe Zimmern
Aug 11, 2015·Proteomics. Clinical Applications·Kyle A FloydMaria Hadjifrangiskou
Oct 14, 2011·International Journal of Antimicrobial Agents·Florian M E WagenlehnerWolfgang Weidner
Aug 31, 2007·International Journal of Antimicrobial Agents·Florian M E WagenlehnerKurt G Naber
Feb 13, 2009·Journal of Applied Microbiology·A MouraJ Azeredo
Oct 2, 2008·European Journal of Clinical Investigation·F M E WagenlehnerW Weidner
Dec 12, 2012·Molecular Immunology·Mohammad Reza Asadi KaramSaeid Bouzari
Feb 7, 2014·Critical Reviews in Food Science and Nutrition·Salvatore MicaliMichele Navarra
May 14, 2016·American Journal of Physiology. Renal Physiology·J Todd Purves, F Monty Hughes
Jul 22, 2010·Nature Reviews. Urology·Greta R Nielubowicz, Harry L T Mobley
Dec 19, 2017·Journal of Drug Targeting·Rahul MittalKusum Harjai
Aug 8, 2014·BMC Research Notes·Manuela OliveiraConstança Pomba
Feb 8, 2020·Antibiotics·Lene K VestbyLive L Nesse
Apr 30, 2017·Der Urologe. Ausg. A·G MagistroC G Stief
Jan 29, 2019·Journal of Nephrology·Marco FiorentinoLoreto Gesualdo
Aug 1, 2009·EcoSal Plus·Harry L T MobleyErin C Hagan
Nov 7, 2015·Microbiology Spectrum·Florian M E WagenlehnerKurt G Naber
Feb 2, 2012·Journal of Proteome Research·Ashish GuptaMahendra Bhandari
Oct 4, 2020·Microbial Pathogenesis·Stylianos VagiosCaroline Mitchell
Sep 1, 2021·Advanced Drug Delivery Reviews·Santhni SubramaniamClive A Prestidge
Nov 26, 2010·The Medical Clinics of North America·Elodi J Dielubanza, Anthony J Schaeffer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.